1. S29 Immunological response to airway Aspergillus in CF is reduced following treatment with the CFTR modulator elexacafor-tezacaftor-ivacaftor. (11th November 2022) Authors: Goldsmith, FP; Francis, N; Tewkesbury, D; Barrett, E; Horsley, A; Barry, P Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗